HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $303,117 | +92596.3% | 7,935 | -12.4% | 0.01% | -10.0% |
Q2 2023 | $327 | -64.8% | 9,061 | -44.6% | 0.01% | -72.2% |
Q4 2022 | $930 | -99.6% | 16,343 | +158.8% | 0.04% | +350.0% |
Q4 2021 | $254,000 | -1.2% | 6,315 | 0.0% | 0.01% | -20.0% |
Q3 2021 | $257,000 | +6.2% | 6,315 | +18.7% | 0.01% | +11.1% |
Q2 2021 | $242,000 | +9.0% | 5,319 | 0.0% | 0.01% | -10.0% |
Q1 2021 | $222,000 | – | 5,319 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |